Impact of Abciximab in Elderly Patients with High-Risk Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: An Observational Registry Study

By Iversen Allan Z.   Galatius Soeren   Pedersen Sune   Madsen Jan K.   Jensen Jan S.  

Drugs & Aging, Vol. 28, Iss. 5, 2011-05 ,pp. : 369-378

Adis International

Access to resources Recommend Favorite

Spotlight on Abciximab in Patients with Ischemic Heart Disease Undergoing Percutaneous Coronary Revascularization

By Ibbotson T.   McGavin J.K.   Goa K.L.  

American Journal of Cardiovascular Drugs, Vol. 3, Iss. 5, 2003-01 ,pp. : 381-386

Adis International

Access to resources Recommend Favorite

Clinical outcomes are similar for abciximab and eptifibatide in patients who undergo percutaneous coronary intervention (PCI), but abciximab is associated with greater costs

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 493, 2005-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Clinical outcomes are similar for abciximab and eptifibatide in patients who undergo percutaneous coronary intervention (PCI), but abciximab is associated with greater costs

By  

Inpharma, Vol. 1, Iss. 1518, 2005-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Association of the use of amlodipine with clopidogrel response in Chinese patients undergoing percutaneous coronary intervention

By  

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 69, Iss. 11, 2014-11 ,pp. : 814-817

Govi-Verlag

Access to resources Recommend Favorite